Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Emcure-Pharmaceuticals"

38 News Found

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
News | April 08, 2023

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.


Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%
Biopharma | May 06, 2026

Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%

Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth


Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court
News | April 20, 2026

Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court

The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage


Akumentis Healthcare appoints Sachhin Misshra as President
People | April 06, 2026

Akumentis Healthcare appoints Sachhin Misshra as President

With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership


Emcure Pharma reduces Poviztra starting dose price by 55% in India
News | April 02, 2026

Emcure Pharma reduces Poviztra starting dose price by 55% in India

The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country


Emcure partners with Roche to boost nephrology and transplant care in India
News | March 02, 2026

Emcure partners with Roche to boost nephrology and transplant care in India

Emcure to distribute Roche's kidney transplant and anemia drugs in India


Emcure Pharma launches weight loss drug Poviztra in India
News | December 22, 2025

Emcure Pharma launches weight loss drug Poviztra in India

Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management


Emcure to acquire remaining stake in Zuventus Healthcare
News | June 23, 2025

Emcure to acquire remaining stake in Zuventus Healthcare

The transaction is expected to close in Q2 FY 2026


Emcutix and WiQo sign licensing partnership for derma-cosmetic treatments in India
News | April 02, 2025

Emcutix and WiQo sign licensing partnership for derma-cosmetic treatments in India

PRX-PLUS has a unique product feature with its deep-impacting formula